Federal Circuit reverses district court in long-fought Shire v Watson ANDA dispute
The Federal Circuit has found Watson did not infringe Shire’s patent for Lialda, noting the “rare” exception established by Norian to the presumptively closed nature of the “consisting of” language
The Federal Circuit has reversed the district court’s finding of infringement against Watson Pharmaceuticals in 2013. Shire filed an infringement suit against Watson in the Southern District of Florida, claiming that Watson’s ANDA product infringed its patent for Lialda, which...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.